THERACRYF PLC (TCF) — Investor Presentation

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Theracryf Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04355-b9ab-7b62-b926-11cdb4ae5e39 Created: 2026-08-27T13:11:44.286Z Duration: 2489.187 Channels: 1 00:00:01.040 -- 00:00:03.840 Good morning, and welcome to the THERACRYF PLC 00:00:03.840 -- 00:00:05.280 Investor Presentation. 00:00:05.359 -- 00:00:07.759 Throughout this recorded presentation, investors will be in 00:00:07.759 -- 00:00:10.320 listen only mode. Questions are encouraged and they 00:00:10.320 -- 00:00:12.160 can be submitted at any time using the 00:00:12.160 -- 00:00:13.759 Q and A tab situated on the right 00:00:13.759 -- 00:00:15.735 hand corner of your screen. Just simply type 00:00:15.735 -- 00:00:17.895 in your questions and press send. Before we 00:00:17.895 -- 00:00:19.414 begin, I would like to submit the following 00:00:19.414 -- 00:00:20.055 poll. 00:00:20.215 -- 00:00:21.335 And I would now like to hand you 00:00:21.335 -- 00:00:22.615 over to CEO, 00:00:22.775 -- 00:00:25.015 Hugh Jones. Good morning to you, sir. Good 00:00:25.015 -- 00:00:27.095 morning, Alex. Good morning, everybody. Thanks for attending. 00:00:27.580 -- 00:00:30.380 I'm Hugh. We've we've probably met before on 00:00:30.380 -- 00:00:32.540 these screens, and with me is doctor Helen 00:00:32.540 -- 00:00:34.460 Kuhlman, our chief operating officer. 00:00:34.860 -- 00:00:38.460 We're gonna dwell today particularly on two RNS 00:00:38.460 -- 00:00:40.300 releases made in the last couple of weeks, 00:00:40.695 -- 00:00:41.735 really about, 00:00:42.135 -- 00:00:44.535 what the significance of the IP 00:00:44.535 -- 00:00:47.975 we've filed is and indeed the significance of, 00:00:48.455 -- 00:00:51.495 through our, smoothed out manufacturing process, 00:00:51.735 -- 00:00:54.375 the two kilograms of clinical grade ...